Tejs Ehlers Klug clinical trials
Tejs Ehlers Klug is the lead sponsor of 3 current clinical trials in our Denmark register. None of its ClinicalTrials.gov trials is recruiting at the moment. The most common phase is Phase 4. The drugs named most often in its trials are Amoxicillin/Clavulanic Acid, Benzylpenicillin and Cefuroxime. The most-studied condition is Tonsillitis Recurrent.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by Tejs Ehlers Klug
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Antibiotic Tissue Penetration and Tissue Response in Head and Neck Infection and Reconstructive Surgery
NCT07896239 · ClinicalTrials.gov ↗ · Surgical Wound Infection, Neck Infection, Nasal Reconstruction
|
Phase 4 | Not yet open | 2026-10 | Denmark |
|
A Single Dose of Intravenous Penicillin as an Adjunct to Oral Penicillin in the Treatment of Acute Tonsillitis, Peritonsillar Phlegmon, and Peritonsillar Abscess
NCT07896226 · ClinicalTrials.gov ↗ · Acute Tonsillitis, Peritonsillar Abscess, Peritonsillar Cellulitis
Drug: Benzylpenicillin |
Phase 4 | Not yet open | 2026-10 | Denmark |
|
Tonsillectomy Versus Tonsillotomy in the Treatment of Recurrent Acute Tonsillitis
NCT06606262 · ClinicalTrials.gov ↗ · Tonsillitis Recurrent
|
Not applicable | Active, closed | 2024-10 | Denmark |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Drugs in Tejs Ehlers Klug trials
5 compoundsDrugs and biologicals named as interventions in these trials, with the number of this sponsor's trials that name each one. Placebos and generic comparators are excluded.
Conditions in Tejs Ehlers Klug trials
7 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Denmark | 3 | 0 |
A trial with sites in more than one country appears in each of those registers.
Questions about Tejs Ehlers Klug trials
How many clinical trials does Tejs Ehlers Klug sponsor?
Tejs Ehlers Klug is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Denmark register, as of the registry sync on 28 October 2026. Completed and withdrawn studies are not counted.
Are Tejs Ehlers Klug trials recruiting?
Not at the moment. None of its 3 ClinicalTrials.gov trials is recruiting; they are active but closed to enrolment, not yet open, or enrolling by invitation. Only the study team can confirm whether a patient is eligible.
Which drugs is Tejs Ehlers Klug testing?
Its current trials name 5 drugs and biologicals as interventions. The most frequent are Amoxicillin/Clavulanic Acid (1), Benzylpenicillin (1), Cefuroxime (1), Cloxacillin (1) and Dicloxacillin (1). The number in brackets is how many of its trials name each drug.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 28 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.